Global Aflatoxin B1 Immunoaffinity Columns IAC Market Insights, Size, and Forecast By End Use (Food and Beverage Industry, Pharmaceutical Industry, Agriculture and Livestock), By Application (Food Safety Testing, Pharmaceutical Analysis, Environmental Monitoring), By Technology (Immunoassay, Chromatography, Mass Spectrometry), By Type (Pre-packed Columns, Custom Columns, Single Use Columns), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035
Key Market Insights
Global Aflatoxin B1 Immunoaffinity Columns IAC Market is projected to grow from USD 0.21 Billion in 2025 to USD 0.39 Billion by 2035, reflecting a compound annual growth rate of 7.2% from 2026 through 2035. This market encompasses the production and distribution of specialized columns utilized for the selective extraction and concentration of Aflatoxin B1 (AFB1) from various matrices prior to analytical detection. These columns leverage the high specificity of antibody antigen reactions, offering a crucial preparatory step in ensuring accurate and reliable quantification of this potent mycotoxin. The market's growth is primarily fueled by stringent global food safety regulations mandating mycotoxin testing, increasing consumer awareness regarding food contamination, and a rising incidence of mycotoxin outbreaks due to climate change impacts on agricultural practices. Technological advancements in IAC design, leading to improved recovery rates and faster analysis times, further bolster market expansion. The dominant segment within this market is Food Safety Testing, which accounts for the largest share of applications, highlighting the critical role IACs play in safeguarding the food supply chain.
Global Aflatoxin B1 Immunoaffinity Columns IAC Market Value (USD Billion) Analysis, 2025-2035
2025 - 2035
www.makdatainsights.com
Key market drivers include the escalating demand for high sensitivity and specificity in mycotoxin detection, driven by a growing understanding of AFB1's carcinogenic and immunosuppressive effects. The globalization of food trade necessitates harmonized testing standards, pushing for wider adoption of advanced analytical techniques like those employing IACs. Furthermore, the expansion of the animal feed industry and the need to prevent mycotoxin transmission through the feed to food chain also contribute significantly to market growth. However, market restraints include the relatively high cost of IACs compared to some conventional extraction methods and the need for skilled personnel to operate the analytical equipment. The complexity of certain sample matrices and the potential for cross reactivity in less optimized columns also pose challenges. Despite these restraints, the market presents significant opportunities through the development of multiplex IACs capable of simultaneously detecting multiple mycotoxins, expanding applications into new product categories such as cannabis and traditional medicines, and the increasing demand for automation in mycotoxin analysis.
Europe stands as the dominant region in the Global Aflatoxin B1 IAC market. This leadership is attributed to its well-established regulatory framework for food safety, a strong emphasis on research and development in mycotoxin analysis, and the presence of major food testing laboratories and key market players. The region's proactive approach to mitigating mycotoxin risks in both food and feed products drives consistent demand for IACs. Conversely, Asia Pacific is projected to be the fastest growing region, driven by rapid economic development, increasing population, rising disposable incomes, and a growing focus on food safety standards in emerging economies like China and India. The expansion of food processing industries and the adoption of international trade standards also fuel this growth. Key players in this competitive landscape include Abcam, PerkinElmer, FST GmbH, SigmaAldrich, Neogen Corporation, Waters Corporation, Romer Labs, Eurofins Scientific, ScioScience, and Gibco. These companies are actively engaged in strategic initiatives such as product innovation, geographical expansion, partnerships, and mergers and acquisitions to strengthen their market position and capitalize on emerging opportunities.
Quick Stats
Market Size (2025):
USD 0.21 BillionProjected Market Size (2035):
USD 0.39 BillionLeading Segment:
Food Safety Testing (72.8% Share)Dominant Region (2025):
Europe (36.8% Share)CAGR (2026-2035):
7.2%
Global Aflatoxin B1 Immunoaffinity Columns IAC Market Emerging Trends and Insights
APAC Aflatoxin Detection Expansion
The APAC region is witnessing a significant surge in aflatoxin B1 detection efforts, driving the expansion of Immunoaffinity Column IAC demand. This trend is fueled by increasing consumer awareness regarding food safety, particularly concerning mycotoxin contamination in staples like rice, corn, and peanuts. Governments in countries like China, India, and Southeast Asian nations are implementing stricter food regulations and enhancing monitoring programs for aflatoxins in domestic and imported food products. Growing investments in laboratory infrastructure and the adoption of advanced analytical methods across the food and feed industries are further propelling this expansion. The need for rapid, accurate, and cost effective aflatoxin testing solutions in APAC is therefore directly translating into increased procurement and utilization of IACs for sample preparation.
Rapid On Site Testing Growth
The global aflatoxin B1 immunoaffinity column market is experiencing significant growth driven by the surge in rapid on site testing. This trend reflects an increasing demand for quick and accessible aflatoxin detection methods outside traditional laboratories. Food processors, farmers, and regulatory bodies are adopting on site testing solutions to facilitate immediate decision making regarding crop management, grain storage, and food product quality control. The ability to perform tests rapidly at the point of need minimizes delays, reduces spoilage, and enhances food safety throughout the supply chain. This shift towards decentralized testing underscores a broader industry move towards more efficient and proactive aflatoxin management strategies, ultimately improving food security and public health outcomes globally.
Multiplex Mycotoxin Column Innovation
Multiplex mycotoxin column innovation reflects a significant evolution in global aflatoxin B1 immunoaffinity columns. Traditionally, these columns focused on isolating single mycotoxins like aflatoxin B1. However, agricultural commodities are often contaminated with multiple mycotoxins simultaneously, including other aflatoxins, ochratoxin, fumonisins, and zearalenone. Analyzing these individually is time consuming and expensive.
The new trend is towards developing columns capable of simultaneously extracting and purifying multiple mycotoxins from a single sample. These multiplex columns integrate various antibodies or binding chemistries within a single device. This advancement streamlines the analytical workflow, reduces sample preparation time, lowers reagent consumption, and provides a more comprehensive mycotoxin profile with fewer analytical steps. It enhances efficiency and cost effectiveness for laboratories performing routine mycotoxin analysis, moving beyond a sole focus on aflatoxin B1.
What are the Key Drivers Shaping the Global Aflatoxin B1 Immunoaffinity Columns IAC Market
Stringent Food Safety Regulations & Trade Compliance
Food safety regulations globally are becoming increasingly strict, particularly concerning mycotoxin contamination like aflatoxin B1. Countries and trade blocs are implementing lower maximum residue limits for aflatoxins in various food and feed products to protect public health and ensure fair trade practices. This stringent regulatory landscape compels food producers, processors, and exporters to implement robust testing protocols to demonstrate compliance. Immunoaffinity columns offer a precise and reliable method for detecting and quantifying aflatoxin B1, making them indispensable for meeting these rigorous standards. Non compliance can lead to product recalls, trade barriers, and significant financial penalties. Consequently, the demand for these advanced testing solutions is driven by the imperative for accurate and efficient aflatoxin B1 detection to facilitate international trade and ensure consumer safety.
Growing Global Awareness of Aflatoxin Contamination & Health Risks
The increasing global understanding of aflatoxin B1 contamination in food and feed is a significant market driver. Consumers, food producers, and regulatory bodies worldwide are becoming more knowledgeable about the severe health risks associated with aflatoxin exposure, including liver cancer and suppressed immune function. This heightened awareness is driven by scientific research, public health campaigns, and international collaborations. As a result, there's a growing demand for effective and reliable methods to detect and quantify aflatoxins. Immunoaffinity columns offer a precise and sensitive solution, essential for ensuring food safety and meeting stringent international trade regulations. This rising consciousness directly translates into greater adoption of these columns across the food and agriculture sectors globally.
Increasing Demand for Rapid & Accurate Aflatoxin Detection in Food & Feed
The growing global concern for food and feed safety is a primary catalyst for the aflatoxin B1 immunoaffinity columns market. Consumers and regulatory bodies worldwide are increasingly aware of the severe health risks posed by aflatoxins, including their carcinogenic properties. This heightened awareness translates into a powerful demand for more sophisticated and efficient detection methods. Importers and food manufacturers face stringent regulations requiring comprehensive testing to prevent contaminated products from entering the supply chain. Consequently, there's a strong drive to adopt technologies like IACs that offer speed, accuracy, and reliability in identifying aflatoxin B1. This urgency stems from a universal desire to protect public health and ensure compliance with evolving food safety standards across international markets.
Global Aflatoxin B1 Immunoaffinity Columns IAC Market Restraints
High Cost of IAC Columns and Instrumentation
The high cost of IAC columns and instrumentation significantly restricts the global aflatoxin B1 market growth. Specialized materials and intricate manufacturing processes contribute to the prohibitive price tags of these immunoaffinity columns. Furthermore, the sophisticated analytical instruments required to operate these columns and interpret results represent a substantial capital investment. This financial barrier limits adoption, particularly for smaller laboratories, academic institutions, and developing countries with constrained budgets. Such high upfront and ongoing operational expenses deter new entrants and hinder widespread implementation of IAC technology, ultimately slowing market expansion and the broader application of these crucial aflatoxin detection methods across various industries.
Lack of Regulatory Harmonization and Standardization
The absence of unified regulations and standards significantly impedes the global aflatoxin B1 immunoaffinity columns market. Different countries and regions impose varying analytical requirements and acceptable limits for aflatoxins in food and feed. This fragmentation necessitates manufacturers to adapt their columns and testing protocols for each specific market, increasing development costs and complexity. Without common benchmarks for performance, quality, and validation of these columns, international trade becomes cumbersome. Laboratories also face challenges in comparing results across borders due to non standardized methodologies. This lack of uniformity hinders market expansion by creating technical barriers to entry and preventing the widespread adoption of specific column technologies, ultimately slowing the market’s growth and innovation.
Global Aflatoxin B1 Immunoaffinity Columns IAC Market Opportunities
Accelerated Demand for Aflatoxin B1 IACs Driven by Stricter Global Mycotoxin Regulations and Cross-Border Trade Expansion
The opportunity for Aflatoxin B1 Immunoaffinity Columns IACs is substantially accelerating due to two powerful global trends. Firstly, a worldwide push towards stricter mycotoxin regulations means governments and international organizations are imposing tougher limits on aflatoxin contamination in food and feed. This tightening compliance environment mandates more rigorous, frequent, and precise testing across the entire supply chain to ensure product safety and protect consumer health. Secondly, the rapid expansion of cross-border trade means a greater volume and variety of agricultural commodities and processed foods are moving between countries. Each shipment must meet the increasingly strict import standards of destination markets, where IACs are indispensable for efficient and accurate sample preparation in aflatoxin detection. This dual pressure of heightened regulatory scrutiny and booming international commerce directly translates into a soaring demand for reliable IAC technologies, creating a significant growth pathway for manufacturers and suppliers, particularly in regions with expanding trade and evolving safety protocols.
Untapped Market Growth in Emerging Economies and Diversified Food & Feed Applications for Aflatoxin B1 IAC Solutions
The significant opportunity lies in addressing the burgeoning need for Aflatoxin B1 testing within emerging economies. These regions, particularly in Asia Pacific, are witnessing rapid agricultural expansion and heightened awareness of food safety standards. As their domestic markets grow and international trade commitments increase, there is an escalating demand for reliable contamination detection solutions like Immunoaffinity Columns.
Beyond geographical expansion, another key avenue for growth involves diversifying the application of Aflatoxin B1 IAC solutions. Currently, many food and feed sectors remain underserved or entirely unaddressed. Expanding IAC use to a broader spectrum of products, including various processed foods, specialty crops, spices, and a wider range of animal feed formulations, presents a substantial opportunity. This dual focus on untapped markets in developing nations and broader application across diversified food and feed categories will drive considerable growth for Aflatoxin B1 IAC solutions.
Global Aflatoxin B1 Immunoaffinity Columns IAC Market Segmentation Analysis
Key Market Segments
By Application
- •Food Safety Testing
- •Pharmaceutical Analysis
- •Environmental Monitoring
By End Use
- •Food and Beverage Industry
- •Pharmaceutical Industry
- •Agriculture and Livestock
By Type
- •Pre-packed Columns
- •Custom Columns
- •Single Use Columns
By Technology
- •Immunoassay
- •Chromatography
- •Mass Spectrometry
Segment Share By Application
Share, By Application, 2025 (%)
- Food Safety Testing
- Pharmaceutical Analysis
- Environmental Monitoring
www.makdatainsights.com
Why is Food Safety Testing dominating the Global Aflatoxin B1 Immunoaffinity Columns IAC Market?
Food Safety Testing holds the largest share due to the critical global imperative to monitor and control aflatoxin B1 contamination in various food products. Regulatory bodies worldwide impose stringent limits on this potent carcinogen in commodities like grains, nuts, and spices. IAC technology provides highly specific and efficient sample cleanup, which is essential for accurate quantification using downstream analytical techniques, ensuring consumer safety and facilitating international trade compliance across diverse food matrices.
What role does the Food and Beverage Industry play in driving demand for Aflatoxin B1 IAC?
The Food and Beverage Industry is a primary end user segment propelling the demand for Aflatoxin B1 IAC. This sector faces immense pressure to ensure the safety and quality of its raw materials and finished products, especially those susceptible to fungal contamination such as cereals, dried fruits, and dairy feeds. Implementing IAC for routine quality control allows manufacturers to meet internal safety standards, comply with national and international regulations, and prevent costly product recalls, thus safeguarding brand reputation and public health.
How do Immunoaffinity Columns contribute to enhanced analytical accuracy for Aflatoxin B1 detection?
Immunoaffinity Columns significantly elevate analytical accuracy by providing highly selective sample purification. While not a standalone detection technology, IAC acts as a crucial pre analytical step, isolating aflatoxin B1 from complex matrices before analysis via methods like chromatography or mass spectrometry. This targeted cleanup removes interfering substances, reduces background noise, and concentrates the analyte, resulting in lower detection limits, improved recovery rates, and more reliable quantitative results across various applications.
Global Aflatoxin B1 Immunoaffinity Columns IAC Market Regulatory and Policy Environment Analysis
The global aflatoxin B1 immunoaffinity column market operates within a stringent and evolving regulatory landscape driven by food safety and public health concerns. International bodies such as Codex Alimentarius establish guidelines for maximum residue limits MRLs of aflatoxins in various food and feed commodities, which serve as foundational benchmarks. Regional authorities like the European Union United States Food and Drug Administration and national agencies in major economies such as China and Brazil often implement specific and frequently stricter MRLs mandating routine testing. These regulations compel manufacturers and distributors across the supply chain to verify compliance ensuring product safety for domestic consumption and international trade. Consequently demand for validated and accurate testing methods employing IACs for sample cleanup before analysis by techniques like HPLC or LC MS/MS is high. Regulatory requirements for method validation and laboratory accreditation further underscore the need for reliable sample preparation tools. Stringent import and export controls particularly for high risk commodities like grains nuts and spices directly influence market demand for IACs as essential components in contamination detection and prevention strategies. Ongoing global harmonization efforts also shape market dynamics by standardizing testing protocols and MRLs.
Which Emerging Technologies Are Driving New Trends in the Market?
The global aflatoxin B1 immunoaffinity columns IAC market is experiencing transformative innovations. Emerging technologies prioritize miniaturization, leading to compact, high throughput columns for rapid sample preparation. Automation is a pivotal trend, integrating IACs into seamless laboratory workflows for enhanced efficiency and reduced manual intervention. Breakthroughs in antibody engineering and solid phase materials are significantly improving column specificity and binding capacity, yielding cleaner extracts and enabling lower detection limits.
Developers are focusing on multi toxin IACs, allowing simultaneous extraction of various mycotoxins, which streamlines analytical processes. Smart features like RFID for column tracking and data management are also emerging. Sustainability is a growing concern, driving research into greener materials and more efficient column designs. These advancements are critical for improving food safety, accelerating testing, and meeting stringent regulatory demands across diverse industries worldwide.
Global Aflatoxin B1 Immunoaffinity Columns IAC Market Regional Analysis
Global Aflatoxin B1 Immunoaffinity Columns IAC Market
Trends, by Region
Europe Market
Revenue Share, 2025
www.makdatainsights.com
Dominant Region
Europe · 36.8% share
Europe commands a significant presence in the global aflatoxin B1 immunoaffinity columns IAC market, holding an impressive 36.8% share. This dominance stems from stringent food safety regulations and robust monitoring programs across European Union member states. Advanced laboratory infrastructure and a strong emphasis on quality control in food and feed production further solidify Europe's leading position. High awareness among consumers and regulatory bodies regarding mycotoxin contamination drives consistent demand for IAC products. Furthermore, ongoing research and development in mycotoxin detection technologies contribute to a mature and expanding market within the region, ensuring continued leadership in this critical sector.
Fastest Growing Region
Asia Pacific · 9.2% CAGR
Asia Pacific is poised to be the fastest growing region in the global Aflatoxin B1 Immunoaffinity Columns IAC market, projecting a robust CAGR of 9.2% during the 2026-2035 forecast period. This significant growth is primarily fueled by increasing awareness of food safety and the stringent regulatory landscape emerging across countries like China and India. The expanding processed food industry, coupled with rising consumer demand for safe and quality agricultural products, drives the adoption of advanced testing methods. Furthermore, government initiatives promoting food quality control and the continuous expansion of testing laboratories in developing economies contribute substantially to this accelerated regional growth, making Asia Pacific a key market driver.
Impact of Geopolitical and Macroeconomic Factors
Geopolitically, the aflatoxin B1 IAC market is influenced by international food safety regulations and trade agreements. Emerging economies in Africa and Asia with high domestic aflatoxin contamination face increased pressure to adopt advanced testing methods, driven by export aspirations and public health concerns. Political stability in key agricultural producing regions directly impacts IAC demand, as disruptions can lead to supply chain vulnerabilities and increased testing requirements. Funding for food safety infrastructure by international organizations further fuels market expansion, especially in developing nations striving for global food market integration.
Macroeconomically, agricultural commodity price fluctuations affect IAC adoption rates. Higher crop prices can stimulate investment in quality control, including aflatoxin testing, to access premium markets. Conversely, economic downturns might prompt cost cutting measures, potentially delaying IAC implementation in less regulated sectors. Technological advancements in automation and rapid testing drive down costs, making IACs more accessible. Public awareness campaigns regarding food safety and the health impacts of aflatoxin contamination also stimulate market growth, increasing demand for reliable and accurate testing solutions across the food industry.
Recent Developments
- March 2025
Neogen Corporation launched a new generation of Aflatoxin B1 IACs, offering enhanced specificity and faster run times. This product aims to reduce detection errors and improve laboratory throughput for food and feed safety testing.
- July 2024
Waters Corporation announced a strategic partnership with Eurofins Scientific to integrate Waters' advanced IAC technology into Eurofins' global network of testing laboratories. This collaboration seeks to standardize and improve the efficiency of aflatoxin testing across various regions.
- November 2024
Romer Labs completed the acquisition of ScioScience, a German-based company specializing in rapid diagnostic solutions for mycotoxins. This acquisition strengthens Romer Labs' portfolio in the global aflatoxin testing market and expands its R&D capabilities.
- February 2025
PerkinElmer introduced a novel automated platform for aflatoxin B1 detection utilizing their proprietary immunoaffinity columns. This system is designed to minimize manual handling, reduce variability, and provide high-throughput analysis for large-scale sample processing.
Key Players Analysis
The Global Aflatoxin B1 Immunoaffinity Columns IAC Market sees key players like Abcam, PerkinElmer, Neogen, and Waters driving innovation. Companies such as SigmaAldrich and Eurofins Scientific contribute significantly through comprehensive product portfolios and testing services. FST GmbH and ScioScience focus on advanced IAC technologies, while Gibco and Romer Labs offer specialized solutions. Strategic initiatives include enhancing detection limits, expanding regional distribution, and developing user friendly extraction kits to meet rising food safety demands and stringent regulatory requirements.
List of Key Companies:
- Abcam
- PerkinElmer
- FST GmbH
- SigmaAldrich
- Neogen Corporation
- Waters Corporation
- Romer Labs
- Eurofins Scientific
- ScioScience
- Gibco
- Beta Analytic
- Biosystems
- Agilent Technologies
- VWR International
- Cambridge Isotope Laboratories
Report Scope and Segmentation
| Report Component | Description |
|---|---|
| Market Size (2025) | USD 0.21 Billion |
| Forecast Value (2035) | USD 0.39 Billion |
| CAGR (2026-2035) | 7.2% |
| Base Year | 2025 |
| Historical Period | 2020-2025 |
| Forecast Period | 2026-2035 |
| Segments Covered |
|
| Regional Analysis |
|
Table of Contents:
List of Figures
List of Tables
Table 1: Global Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 2: Global Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 3: Global Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Type, 2020-2035
Table 4: Global Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Technology, 2020-2035
Table 5: Global Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Region, 2020-2035
Table 6: North America Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 7: North America Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 8: North America Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Type, 2020-2035
Table 9: North America Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Technology, 2020-2035
Table 10: North America Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Country, 2020-2035
Table 11: Europe Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 12: Europe Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 13: Europe Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Type, 2020-2035
Table 14: Europe Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Technology, 2020-2035
Table 15: Europe Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 16: Asia Pacific Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 17: Asia Pacific Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 18: Asia Pacific Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Type, 2020-2035
Table 19: Asia Pacific Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Technology, 2020-2035
Table 20: Asia Pacific Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 21: Latin America Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 22: Latin America Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 23: Latin America Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Type, 2020-2035
Table 24: Latin America Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Technology, 2020-2035
Table 25: Latin America Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035
Table 26: Middle East & Africa Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Application, 2020-2035
Table 27: Middle East & Africa Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by End Use, 2020-2035
Table 28: Middle East & Africa Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Type, 2020-2035
Table 29: Middle East & Africa Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Technology, 2020-2035
Table 30: Middle East & Africa Aflatoxin B1 Immunoaffinity Columns IAC Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035